Chargement en cours...
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
OBJECTIVE: To determine the safety profile of anakinra after extended exposure in a diverse clinical trial population of patients with rheumatoid arthritis. METHODS: A six month, randomised, double blind phase comparing anakinra (100 mg/day) with placebo was followed by open label anakinra treatment...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Group
2006
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1798263/ https://ncbi.nlm.nih.gov/pubmed/16396977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.048371 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|